Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 7 February

Sophia Mavridis
February 7, 2022

Weekly Wrap 4 February

Sophia Mavridis
February 4, 2022

Morning Bell 3 February

Paulina Peters
February 3, 2022

Morning Bell February 2

Sophia Mavridis
February 2, 2022

Morning Bell 1 February

Paulina Peters
February 1, 2022

Morning Bell 31 January

Sophia Mavridis
January 31, 2022

Weekly Wrap 28 January

Sophia Mavridis
January 28, 2022

Morning Bell 27 January

Sophia Mavridis
January 27, 2022

Morning Bell 25 January

Paulina Peters
January 25, 2022

Morning Bell 24 January

Paulina Peters
January 24, 2022

Weekly Wrap 21 January

Sophia Mavridis
January 21, 2022

Morning Bell 20 January

Paulina Peters
January 20, 2022